NEWS Flash...
Lambda acquires North American CRO, Biovail CRD, Toronto, Canada
Click here for Press Release

 
NEWS Archive
 


Lambda NewsLetter, click here...

 
 
Our Accomplishments
In 2009,
Successful US FDA inspection of all 5 clinical trial sites and Ahmedabad Facility
Successful inspection of Ahmedabad and Mumbai facilities by OGYI - Hungarian Medical Regulatory Authority
Successful inspection of Poland Facilities by Austrian Regulatory Authority
more...

List of all available assays, click here...

Lambda at a Glance:

bullet One of the fastest growing names in the domain of clinical research
bullet A leading multinational CRO with head office in Ahmedabad, India and branch at Mumbai, India; Warsaw, Poland and USA
bullet A team of over 500 committed personnel across its offices empowered by state-of-the-art infrastructure
bullet Works on all aspects of Clinical Drug Development including Clinical trials, Clinical laboratory, Data management, Bioequivalence/Bioavailability studies
 

Capabilities & Services...

Early Clinical Development Services – Phase I Units
Late Phase Clinical Trial Management and Monitoring Services
ECG Core Laboratory Services – TQT studies
Bioanalytical Services
Central Clinical Laboratory Services
Clinical Data Management Services
Pharmacovigilance
Biostatistics and Programming Services
Medical Writing Services
Bioavailability and Bioequivalence Services – 457 beds
Project Management and Pharmacokinetics
Quality Assurance

 

Lambda Therapeutic Research Ltd.
A CRO for Clinical Research, Clinical Trials, Medical Writing, Bioanalytical, Bioequivalence and Pharmacovigilance services.
India (Ahmedabad - Mumbai), Poland (Warsaw), USA